These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9342358)

  • 1. Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function.
    Otterson GA; Chen Wd; Coxon AB; Khleif SN; Kaye FJ
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12036-40. PubMed ID: 9342358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature-sensitive RB mutations linked to incomplete penetrance of familial retinoblastoma in 12 families.
    Otterson GA; Modi S; Nguyen K; Coxon AB; Kaye FJ
    Am J Hum Genet; 1999 Oct; 65(4):1040-6. PubMed ID: 10486322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors.
    Kratzke RA; Otterson GA; Hogg A; Coxon AB; Geradts J; Cowell JK; Kaye FJ
    Oncogene; 1994 May; 9(5):1321-6. PubMed ID: 8152792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.
    Whitaker LL; Su H; Baskaran R; Knudsen ES; Wang JY
    Mol Cell Biol; 1998 Jul; 18(7):4032-42. PubMed ID: 9632788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
    Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
    Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.
    Bremner R; Du DC; Connolly-Wilson MJ; Bridge P; Ahmad KF; Mostachfi H; Rushlow D; Dunn JM; Gallie BL
    Am J Hum Genet; 1997 Sep; 61(3):556-70. PubMed ID: 9326321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Sellers WR; Rodgers JW; Kaelin WG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
    Flemington EK; Speck SH; Kaelin WG
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6914-8. PubMed ID: 8346196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
    Welch PJ; Wang JY
    Genes Dev; 1995 Jan; 9(1):31-46. PubMed ID: 7828850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
    Arroyo M; Raychaudhuri P
    Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity.
    Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS
    Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of BRCA1 expression by the Rb-E2F pathway.
    Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG
    J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis.
    Shan B; Durfee T; Lee WH
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):679-84. PubMed ID: 8570615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
    Wang S; Nath N; Minden A; Chellappan S
    EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A; Espanel X; Brun G
    Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.
    Hsieh JK; Fredersdorf S; Kouzarides T; Martin K; Lu X
    Genes Dev; 1997 Jul; 11(14):1840-52. PubMed ID: 9242491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
    Kim YW; Otterson GA; Kratzke RA; Coxon AB; Kaye FJ
    Mol Cell Biol; 1994 Nov; 14(11):7256-64. PubMed ID: 7935440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered mutants of pRB with improved growth suppression potential.
    Antelman D; Perry S; Hollingsworth R; Gregory RJ; Driscoll B; Fung YK; Bookstein R
    Oncogene; 1997 Dec; 15(23):2855-66. PubMed ID: 9419977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.